This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (578)

Published on in Vol 5, No 2 (2016): Apr-Jun

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol

Authors of this article:

Melvin Y Rincon1, 2 Author Orcid Image ;   Carlos E Prada1, 3 Author Orcid Image ;   Marcos Lopez4, 5 Author Orcid Image ;   Victor Castillo1 Author Orcid Image ;   Luis Eduardo Echeverria1 Author Orcid Image ;   Norma Serrano1 Author Orcid Image
Article Authors Cited by (6) Tweetations (1) Metrics

Melvin Y Rincon   1, 2 , MD, PhD ;   Carlos E Prada   1, 3 , MD ;   Marcos Lopez   4, 5 , PhD ;   Victor Castillo   1 , MD ;   Luis Eduardo Echeverria   1 , MD ;   Norma Serrano   1 , MSc, MD

1 Centro de Investigaciones, Fundacion Cardiovascular de Colombia, Floridablanca, Colombia

2 Department of Gene Therapy and Regenerative Medicine, Free University of Brussels (VUB), Brussels, Belgium

3 Division of Human Genetics, Cincinnati Children’s Hospital Medical Center (CCHMC), Cincinnati, OH, United States

4 Translational Biomedical Research Group, Biotechnology Laboratories, Fundación Cardiovascular de Colombia, Floridablanca, Colombia

5 Graduate Program in Biomedical Sciences, Faculty of Health, Universidad del Valle, Cali, Colombia

Corresponding Author:

  • Melvin Y Rincon, MD, PhD
  • Centro de Investigaciones
  • Fundacion Cardiovascular de Colombia
  • Calle 155A No. 23 - 58
  • Floridablanca
  • Colombia
  • Phone: 57 7 6796470
  • Fax: 57 7 6399292
  • Email: rinconmy@gmail.com